SERIAL MEASUREMENT OF CA 125 IN PATIENTS WITH PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE

被引：27
|
作者：
TOKUNAGA, T [1 ]
MIYAZAKI, K [1 ]
MATSUYAMA, S [1 ]
OKAMURA, H [1 ]
机构：
[1] KUMAMOTO UNIV,SCH MED,KUMAMOTO 860,JAPAN
来源：
GYNECOLOGIC ONCOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0090-8258(90)90137-A
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Serial assay of serum CA 125 was carried out in five patients with advanced primary carcinoma of the fallopian tube. Pretreatmental levels of these patients were elevated, ranging from 145 to 535 U/ml (305 ± 140.1, mean ± SD). All patients showed rapid decreases in response to treatment; however, reelevations were noted in two patients concomitant with recurrence. In the remaining three patients, who are alive with no evidence of recurrence at 52,29, and 21 months, serum CA 125 levels remained below 5 U/ml after remission. These results suggest that CA 125 is useful in monitoring patients with primary carcinoma of the fallopian tube. © 1990.
引用
下载
收藏
页码：335 / 337
页数：3
相关论文
共 50 条
  • [21] AN UNUSUAL HYSTEROSCOPIC FINDING IN ASSOCIATION WITH PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE
    FINIKIOTIS, G
    OSHEA, RT
    SANDERS, RR
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1990, 44 (02): : 124 - 125
  • [22] TRANSITIONAL-CELL CARCINOMA PATTERN IN PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE
    UEHIRA, K
    HASHIMOTO, H
    TSUNEYOSHI, M
    ENJOJI, M
    CANCER, 1993, 72 (08) : 2447 - 2456
  • [23] THE MANAGEMENT OF PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE - EXPERIENCE OF 40 CASES
    DENHAM, JW
    MACLENNAN, KA
    CANCER, 1984, 53 (01) : 166 - 172
  • [24] PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE - A CLINICAL-STUDY OF 37 CASES
    ENGELER, V
    REINISCH, E
    SCHREINER, WE
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1981, 41 (05) : 325 - 329
  • [25] TREATMENT OF PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE - RETROSPECTIVE STUDY OF 30 CASES
    KAYA, S
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 988 - 990
  • [26] HER-2 ONCOGENE IS NOT AMPLIFIED IN PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE
    STUHLINGER, M
    ROSEN, AC
    DOBIANER, K
    HRUZA, C
    HELMER, H
    KLEIN, M
    KOUKAL, T
    REINER, A
    KLEIN, M
    SPONA, J
    ONCOLOGY, 1995, 52 (05) : 397 - 399
  • [27] PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE - EVIDENCE FOR ACTIVITY OF CISPLATIN COMBINATION THERAPY
    MAXSON, WZ
    STEHMAN, FB
    ULBRIGHT, TM
    SUTTON, GP
    EHRLICH, CE
    GYNECOLOGIC ONCOLOGY, 1987, 26 (03) : 305 - 313
  • [28] PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE - EVIDENCE FOR ACTIVITY OF CISPLATIN IN COMBINATION THERAPY
    MAXSON, WZ
    STEHMAN, FB
    ULBRIGHT, TM
    SUTTON, GP
    EHRLICH, CE
    GYNECOLOGIC ONCOLOGY, 1985, 20 (02) : 247 - 248
  • [29] EVALUATION OF ADJUVANT THERAPY AFTER SURGERY FOR PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE
    KLEIN, M
    ROSEN, A
    LAHOUSEN, M
    GRAF, A
    VAVRA, N
    PAKISCH, B
    POSCHAUKO, J
    BECK, A
    KUCERA, H
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1994, 255 (01) : 19 - 24
  • [30] OUTCOME OF THERAPY FOR PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE - ANALYSIS OF 43 CASES
    GOETZE, B
    EBERT, A
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 990 - 991
12345